KR20110066201A - 할로겐화 환형 화합물의 합성 방법 - Google Patents

할로겐화 환형 화합물의 합성 방법 Download PDF

Info

Publication number
KR20110066201A
KR20110066201A KR1020117009786A KR20117009786A KR20110066201A KR 20110066201 A KR20110066201 A KR 20110066201A KR 1020117009786 A KR1020117009786 A KR 1020117009786A KR 20117009786 A KR20117009786 A KR 20117009786A KR 20110066201 A KR20110066201 A KR 20110066201A
Authority
KR
South Korea
Prior art keywords
formula
group
alkyl group
compound
adduct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117009786A
Other languages
English (en)
Korean (ko)
Inventor
막스 브라운
Original Assignee
솔베이(소시에떼아노님)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 솔베이(소시에떼아노님) filed Critical 솔베이(소시에떼아노님)
Publication of KR20110066201A publication Critical patent/KR20110066201A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/803—Processes of preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
KR1020117009786A 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법 Ceased KR20110066201A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08165547.4 2008-09-30
EP08165547 2008-09-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020167031136A Division KR20160131129A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법

Publications (1)

Publication Number Publication Date
KR20110066201A true KR20110066201A (ko) 2011-06-16

Family

ID=40351699

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020117009786A Ceased KR20110066201A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법
KR1020167031136A Ceased KR20160131129A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법
KR1020197018768A Ceased KR20190080972A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020167031136A Ceased KR20160131129A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법
KR1020197018768A Ceased KR20190080972A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법

Country Status (7)

Country Link
US (2) US8431710B2 (enExample)
EP (1) EP2334645B1 (enExample)
JP (5) JP6180705B2 (enExample)
KR (3) KR20110066201A (enExample)
CN (2) CN106083710B (enExample)
CA (1) CA2735921C (enExample)
WO (1) WO2010037688A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101652539B1 (ko) 2008-07-04 2016-08-30 솔베이(소시에떼아노님) 알케논의 제조 방법
CN106083710B (zh) * 2008-09-30 2021-03-12 索尔维公司 用于合成卤化的环状化合物的方法
GB0903749D0 (en) * 2009-03-04 2009-04-15 Syngenta Participations Ag Chemical process
ES2537676T3 (es) 2009-07-06 2015-06-10 Solvay Sa Proceso para la fabricación de precursores halogenados de alquenonas en presencia de un disolvente
US8957254B2 (en) 2009-07-06 2015-02-17 Solvay Sa Process for chemical synthesis from an alkenone made from a halogenated precursor
EP2662359A1 (en) 2012-05-08 2013-11-13 Solvay Sa Ionic Liquids, Method for manufacturing thereof, and Electrochemical Devices Comprising the Same
IN2015DN00635A (enExample) * 2012-08-22 2015-06-26 Solvay
JP6449169B2 (ja) 2012-12-20 2019-01-09 ソルヴェイ（ソシエテ アノニム） 電解質中の成分としての窒素含有複素環式アニオンの塩
MX2015017640A (es) * 2013-06-20 2016-09-07 Basf Se Proceso para preparar compuestos de piridilpirazol y sus derivados de piridilhidrazina.
EP2987782A1 (en) 2014-08-22 2016-02-24 Solvay SA Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide
EP3221289A1 (en) 2014-11-17 2017-09-27 Solvay SA Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide
WO2016079122A1 (en) 2014-11-17 2016-05-26 Solvay Sa A method for producing a chemical compound and apparatus therefor
EP3031791A1 (en) 2014-12-10 2016-06-15 Solvay SA Halogenation process of 1,1-dihaloethene
EP3199522A1 (en) 2016-02-01 2017-08-02 Solvay SA Aminothioate derivatives, production thereof and use
WO2019043238A1 (en) 2017-09-04 2019-03-07 Solvay Sa PROCESS AND INTERMEDIARY FOR MANUFACTURING DIFLUOROACETYL CHLORIDE
WO2020093715A1 (en) 2018-11-07 2020-05-14 Fujian Yongjing Technology Co., Ltd New process for manufacture of pyrazoles or pyrimidones
ES2939695T3 (es) * 2018-12-27 2023-04-26 Corteva Agriscience Llc Preparación de intermedios de un proceso de herbicidas de sulfonamida
CN115038690A (zh) 2020-01-31 2022-09-09 索尔维公司 用于制造卤代烷基取代的吡啶化合物的方法
JP2021079146A (ja) * 2021-02-22 2021-05-27 株式会社三洋物産 遊技機
JP7315071B2 (ja) * 2021-03-03 2023-07-26 株式会社三洋物産 遊技機

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420166A1 (de) * 1984-05-30 1985-12-05 Basf Ag, 6700 Ludwigshafen Pyrimidylphosphorsaeureester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
EP0502740B1 (en) * 1991-03-07 1998-05-27 E.I. Du Pont De Nemours And Company Herbicidal pyridine sulfonamide
US5235060A (en) * 1991-07-11 1993-08-10 E. I. Du Pont De Nemours And Company Certain three component ionic substituted pyridine compounds as intermediates for preparation as herbicides
DE4128828A1 (de) 1991-08-30 1993-03-04 Basf Ag Ammonium- oder harnstoffhaltige duengemittel und verfahren zu ihrer herstellung
EP0664805A1 (en) 1992-10-13 1995-08-02 Smithkline Beecham Plc Heterocyclic -esters or -amides used as 5-ht 4? receptor antagonists
ES2119952T3 (es) * 1993-12-23 1998-10-16 Solvay Fluor & Derivate Procedimiento para la preparacion de cloruros de acidos polifluoroclorocarboxilicos y perfluorocarboxilicos bajo adicion de cloro.
JP3843152B2 (ja) * 1995-08-08 2006-11-08 石原産業株式会社 ４−アルコキシ−１，１，１−トリフルオロ−３−ブテン−２−オンの製造方法
GB2305174A (en) 1995-09-15 1997-04-02 Zeneca Ltd Chemical process
GB9711114D0 (en) * 1997-05-29 1997-07-23 Merck Sharp & Dohme Therapeutic agents
DE19821088A1 (de) 1998-05-12 1999-11-18 Basf Ag Modifizierte Polykondensate der Asparaginsäure, Verfahren zu ihrer Herstellung und ihre Verwendung in Düngemitteln
WO2002053518A2 (en) 2000-12-29 2002-07-11 Honeywell International, Inc. HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS
CN100357273C (zh) 2003-03-07 2007-12-26 辛根塔参与股份公司 取代的烟酸酯的制备方法
DE10325715A1 (de) * 2003-06-06 2004-12-23 Solvay Fluor Und Derivate Gmbh Vereinfachte Herstellung von Alkenonen
WO2006058201A2 (en) * 2004-11-23 2006-06-01 Reddy Us Therapeutics, Inc. Heterocyclic and bicyclic compounds, compositions and methods
DE102004061593A1 (de) 2004-12-21 2006-06-22 Abbott Gmbh & Co. Kg Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
EP1940842B1 (en) 2005-09-29 2012-05-30 Merck Sharp & Dohme Corp. Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
JP5112082B2 (ja) * 2006-02-02 2013-01-09 クミアイ化学工業株式会社 ピリドン誘導体及び除草剤
US8729059B2 (en) * 2007-02-09 2014-05-20 Emory University Paramyxovirus family inhibitors and methods of use thereof
EP1987717A1 (de) * 2007-04-30 2008-11-05 Bayer CropScience AG Pyridoncarboxamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung
EP2008996A1 (en) * 2007-06-27 2008-12-31 Syngeta Participations AG Process for the production of pyrazoles
MX2011000196A (es) 2008-07-01 2011-03-24 Dow Agrosciences Llc Proceso mejorado para la preparacion de alquilpiridinas 2-trifluorometil-5-(1-sustituidas).
KR101652539B1 (ko) 2008-07-04 2016-08-30 솔베이(소시에떼아노님) 알케논의 제조 방법
EP2154167A1 (de) * 2008-07-30 2010-02-17 Bayer MaterialScience AG Elektromechanischer Wandler mit einem Polymerelement auf Polyisocyanat-Basis
CN106083710B (zh) * 2008-09-30 2021-03-12 索尔维公司 用于合成卤化的环状化合物的方法
WO2011003860A1 (en) 2009-07-06 2011-01-13 Solvay Sa Process for the manufacture of alkenones
CA2765487A1 (en) 2009-07-06 2011-01-13 Solvay Sa Process for the manufacture of halogenated precursors of alkenones under specific conditions
ES2537676T3 (es) 2009-07-06 2015-06-10 Solvay Sa Proceso para la fabricación de precursores halogenados de alquenonas en presencia de un disolvente
JP6194245B2 (ja) * 2013-12-27 2017-09-06 株式会社Ｓｕｂａｒｕ 信号機認識装置

Also Published As

Publication number Publication date
JP2018058869A (ja) 2018-04-12
JP2020023533A (ja) 2020-02-13
CA2735921A1 (en) 2010-04-08
WO2010037688A1 (en) 2010-04-08
US20110178297A1 (en) 2011-07-21
CN106083710A (zh) 2016-11-09
KR20190080972A (ko) 2019-07-08
JP2022028792A (ja) 2022-02-16
US8981115B2 (en) 2015-03-17
CN102164898A (zh) 2011-08-24
JP6511346B2 (ja) 2019-05-15
EP2334645A1 (en) 2011-06-22
JP2015227339A (ja) 2015-12-17
CA2735921C (en) 2017-03-21
JP6180705B2 (ja) 2017-08-16
JP2012504153A (ja) 2012-02-16
US20130237710A1 (en) 2013-09-12
EP2334645B1 (en) 2019-11-06
JP6647268B2 (ja) 2020-02-14
CN106083710B (zh) 2021-03-12
US8431710B2 (en) 2013-04-30
KR20160131129A (ko) 2016-11-15

Similar Documents

Publication Publication Date Title
JP6647268B2 (ja) ハロゲン化環式化合物の合成方法
MXPA01012485A (es) Dinitrilos de acido arilmalonico sustituidos como intermediarios para la preparacion de herbicidas.
US6462195B1 (en) Methods for highly selectively o-alkylating amide compounds with the use of copper salts
US20100029939A1 (en) Preparation of ketone amides
JPWO1999044969A1 (ja) 銅塩を用いるアミド化合物の高選択的ｏ−アルキル化方法
EP0899262B1 (en) Process for the preparation of heteroarylcarboxylic amides and esters
US6320053B1 (en) Preparation of heteroarylcarboxamides
JPH0713063B2 (ja) 新規ジアミン類
US5011927A (en) Preparation of 2-amino-4-fluoropyrimidine derivatives
JP2991832B2 (ja) ピリミジン誘導体の製造方法
JP3085513B2 (ja) ５−クロロ−４−ヒドロキシ−６−メチルピリミジンの製法
CN110352193A (zh) 制备4-[(4,5-二氢-3-甲氧基-4-甲基-5-氧代-1h-1,2,4-三唑-1-基)羰基)氨磺酰基]-5-甲基噻吩-3-甲酸甲酯的方法
JP2008517967A (ja) フェニル２−ピリミジニルケトン類の製造方法及びその新規中間体
CZ289774B6 (cs) Způsob výroby arylamidů heteroaromatických karboxylových kyselin
CZ66299A3 (cs) Syntéza beta-ketoesteru hydrazonu reakcí s diazoesterem
JPH0348905B2 (enExample)
HK1018060B (en) Process for the preparation of heteroarylcarboxylic amides and esters
JPH1077270A (ja) ２−（１−クロロビニル）ピリジン誘導体およびその製造方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110429

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140825

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20151126

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160808

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20151126

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20161107

PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20160808

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20160426

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20161129

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20161107

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20160808

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20160426

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20151126

X601 Decision of rejection after re-examination